Aimei Health Technology Co., Ltd. AFJK
- Market cap
- $38.6M
- P/E
- 60.0×
Follow AFJK
Target Price Range
Analyst price targets
Free account| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | 10.15 | 6.75 |
Analyst estimates 2026–2028 Powerpack |
Low Price
|
||
| — | — | — | — | — | — | — | — | 10.70 | 130.37 |
High Price
|
|||
| — | — | — | — | — | — | — | 2 | 2 | 2 |
Employees
|
|||
| — | — | — | — | — | — | — | 0 | 0 | 0 |
Revenue/Emp
|
|||
| — | — | — | — | — | — | — | — | — | — | Revenue | |||
| — | — | — | — | — | — | — | — | — | — | Gross Margin | |||
| — | — | — | — | — | — | — | 0 | 3 | 1 |
EBT
|
|||
| — | — | — | — | — | — | — | 0.00% | 0.00% | 0.00% |
EBT Margin
|
|||
| — | — | — | — | — | — | — | 0 | 3 | 1 |
Net Income
|
|||
| — | — | — | — | — | — | — | — | — | — | Depreciation | |||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Revenue/Sh
|
|||
| — | — | — | — | — | — | — | 0.11 | 1.20 | 0.50 |
Earnings/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | (0.32) | (0.27) |
Cash Flow/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | 0.00 | 0.00 |
Capex/Sh
|
|||
| — | — | — | — | — | — | — | 0.00 | (0.32) | (0.27) |
Free CF/Sh
|
|||
| — | — | — | — | — | — | — | (0.09) | (0.69) | (1.91) |
Book Value/Sh
|
|||
| — | — | — | — | — | — | — | 2 | 2 | 2 |
Shares
|
|||
| — | — | — | — | — | — | — | — | — | — | PE Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PS Ratio | |||
| — | — | — | — | — | — | — | — | — | — | PB Ratio | |||
| — | — | — | — | — | — | — | — | — | — | EV/Sales | |||
| — | — | — | — | — | — | — | — | — | — | EV/FCF | |||
| — | — | — | — | — | — | — | 0 | (1) | (1) |
Op' Cash Flow
|
|||
| — | — | — | — | — | — | — | — | — | — | Capex | |||
| — | — | — | — | — | — | — | 0 | (1) | (1) |
FCF
|
|||
| — | — | — | — | — | — | — | 1 | (1) | (3) |
Working Cap'
|
|||
| — | — | — | — | — | — | — | — | 0 | 2 |
Total Debt
|
|||
| — | — | — | — | — | — | — | (1) | 0 | 2 |
Net Debt
|
|||
| — | — | — | — | — | — | — | 0 | (1) | (4) |
Sh' Equity
|
|||
| — | — | — | — | — | — | — | 0.00% | 3.54% | 2.47% |
ROA
|
|||
| — | — | — | — | — | — | — | 0.00% | 0.00% | 0.00% |
ROIC
|
|||
| — | — | — | — | — | — | — | 0.00% | (316.91%) | (38.29%) |
ROE
|
|||
Aimei Health Technology Co., Ltd. peers in Shell Companies
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| WINV WinVest Acquisition Corp. | $39.2M | 0.0× | Compare |
| NOEM CO2 Energy Transition Corp. | $39.4M | 28.7× | Compare |
| FSHP Flag Ship Acquisition Corporation | $39.8M | — | Compare |
| LCCC Lakeshore Acquisition III Corp. | $40.5M | — | Compare |
| Company | Market cap | P/E | Compare |
|---|---|---|---|
| MCAG Mountain Crest Acquisition Corp. V | $36.2M | 0.0× | Compare |
| IGTA Inception Growth Acquisition Limited | $41.6M | 0.4× | Compare |
| YOTA Yotta Acquisition Corporation | $41.7M | 14.3× | Compare |
| DTSQ DT Cloud Star Acquisition Corporation | $42.0M | — | Compare |
Aimei Health Technology Co., Ltd. (AFJK) key facts
- Aimei Health Technology Co., Ltd. (AFJK) is a Shell Companies company in the Financial sector, listed on Nasdaq.
- Net income was $1.1 million, or $0.50 per share (basic), a net margin of 0.00%.
- As of September 25, 2026, AFJK traded at $12.19, a market capitalization of $38.6 million.
- At that price the stock trades at 60.0× trailing-twelve-month earnings.
- Return on equity was −38.3% and debt-to-equity -0.49.
Aimei Health Technology Co., Ltd. (AFJK) Latest News
8 Jul
Aimei Health Technology Co., Ltd. (AFJK) terminated its business combination agreement with United Hydrogen Group Inc. Failed merger deal alters AFJK's growth strategy and market positioning.
20 May
Aimei Health Technology Co., Ltd. (AFJK) received a NASDAQ notice regarding its delayed quarterly report. A NASDAQ delinquency notice for late filings raises compliance risks that can pressure short-term stock sentiment and trigger remediation steps.
21 Apr
Aimei Health Technology Co., Ltd. (AFJK) received a NASDAQ notice citing delay in filing its annual report. NASDAQ notice for delayed annual report signals compliance risks, potential delisting, and damaged investor confidence.
20 Jun
United Hydrogen Group Inc. and Aimei Health Technology Co., Ltd. have entered into a definitive business combination agreement for a merger, making United Hydrogen a publicly traded company on Nasdaq. The transaction values the combined company at an estimated enterprise value of approximately US$1.6 billion. The merger with United Hydrogen Group Inc. is a significant strategic move that is expected to fundamentally alter Aimei Health Technology Co., Ltd.'s competitive position and long-term prospects.
United Hydrogen Group Inc. and Aimei Health Technology Co., Ltd. have entered into a definitive business combination agreement for a merger. The transaction values the combined company at an estimated enterprise value of approximately US$1.6 billion. United Hydrogen is a comprehensive hydrogen solution provider, while Aimei Health Technology Co., Ltd. is a Cayman Islands special purpose acquisition company. The merger between United Hydrogen and Aimei Health Technology Co., Ltd. is expected to have a significant impact on the future and market performance of both companies, potentially altering their competitive positioning and long-term prospects.